Back
Cullinan Therapeutics Stock Price Chart
9,530x the last time this happened
Here's what our expert says you should buy before April 14.
Buy
85
CGEM
Cullinan Therapeutics
Last Price:
27.78
Seasonality Move:
4.4%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!- The current trend is moderately bullish and CGEM is experiencing slight buying pressure.
Cullinan Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.65 | Buy |
| 20-day SMA: | 21.41 | Buy |
| 50-day SMA: | 18.78 | Buy |
| 200-day SMA: | 12.77 | Buy |
| 8-day EMA: | 26.78 | Buy |
| 20-day EMA: | 23.11 | Buy |
| 50-day EMA: | 19.65 | Buy |
| 200-day EMA: | 14.54 | Buy |
Cullinan Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.18 | Buy |
| Relative Strength Index (14 RSI): | 81.51 | Buy |
| Chaikin Money Flow: | 206453 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.54 - 25.52) | Buy |
| Bollinger Bands (100): | (11.29 - 20.75) | Buy |
Cullinan Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cullinan Therapeutics Stock
Is Cullinan Therapeutics Stock a Buy?
- Cullinan Therapeutics share price is 29.34 while CGEM 8-day simple moving average is 27.65, which is a Buy signal.
- The stock price of CGEM is 29.34 while Cullinan Therapeutics 20-day SMA is 21.41, which makes it a Buy.
- Cullinan Therapeutics 50-day simple moving average is 18.78 while CGEM share price is 29.34, making it a Buy technically.
- CGEM stock price is 29.34 and Cullinan Therapeutics 200-day simple moving average is 12.77, creating a Buy signal.
CGEM Technical Analysis vs Fundamental Analysis
Buy
85
Cullinan Therapeutics (CGEM)
is a Buy
Is Cullinan Therapeutics a Buy or a Sell?
-
Cullinan Therapeutics stock is rated a Buy
The current Cullinan Therapeutics [CGEM] share price is $29.34. The Score for CGEM is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
Cullinan Therapeutics Stock Info
Market Cap:
1.26B
Price in USD:
29.34
Share Volume:
809.12K
Cullinan Therapeutics 52-Week Range
52-Week High:
30.19
52-Week Low:
7.64
Buy
85
Cullinan Therapeutics (CGEM)
is a Buy
Cullinan Therapeutics Share Price Forecast
-
What is the Cullinan Therapeutics stock price today?
The Cullinan Therapeutics stock price is 29.34 USD today. -
Will CGEM stock go up or go down?
Cullinan Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Cullinan Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cullinan Therapeutics is not overvalued.
Is Cullinan Therapeutics Stock a Buy?
- Cullinan Therapeutics share price is 29.34 while CGEM 8-day exponential moving average is 26.78, which is a Buy signal.
- The stock price of CGEM is 29.34 while Cullinan Therapeutics 20-day EMA is 23.11, which makes it a Buy.
- Cullinan Therapeutics 50-day exponential moving average is 19.65 while CGEM share price is 29.34, making it a Buy technically.
- CGEM stock price is 29.34 and Cullinan Therapeutics 200-day simple moving average is 14.54, creating a Buy signal.
Fundamental Analysis of Cullinan Therapeutics
Is Cullinan Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.06 per share, an increase this year of $0.57 per share, and an increase next year of $0.23 per share.
Technical Analysis of Cullinan Therapeutics
Should I short Cullinan Therapeutics stock?
- CGEM Moving Average Covergence Divergence (MACD) indicator is 3.18, suggesting Cullinan Therapeutics is a Buy
- Cullinan Therapeutics Relative Strength Index (RSI) is 81.51, which suggest Cullinan Therapeutics is overbought
- The Bollinger Bands (25) for Cullinan Therapeutics is (15.54 - 25.52), which suggest Cullinan Therapeutics is a Buy
- The Bollinger Bands (100) for Cullinan Therapeutics is (11.29 - 20.75), which suggest Cullinan Therapeutics is a Buy
* Cullinan Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.